Brought to you by the National Comprehensive Cancer Network® (NCCN®)
Powered by Syandus Simulation Technology
Are You Up for the Challenge?
The Advanced Non-Small Cell Lung Cancer Patient Management Simulator provides virtual experiences that can help you treat your patients with cancer. The simulation creates a risk-free virtual environment for you to 1) simulate and recognize the various clinical presentations for advanced non-small cell lung cancer (NSCLC), 2) develop an appropriate NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) driven treatment plan, and 3) explore approved drug indications and emerging therapies to integrate with your treatment approaches for patients with NSCLC.
Earn up to 2 Credit Hours as a Physician, Nurse, or Other Health Care Professional and learn how to:
- Define the recommended agents for subsequent therapy for patients with metastatic NSCLC
- Discuss the new immunotherapeutic agents with their patients who have metastatic NSCLC
- Summarize the sequencing of therapy for patients with sensitizing EGFR mutations
- Outline the sequencing of therapy for patients with metastatic wild-type NSCLC
- Identify the recommended treatment for older patients with metastatic NSCLC and explain the related comorbidities
- Apply the appropriate use of new immunotherapeutic agents for patients with metastatic NSCLC
How Does the Simulation Work?
Test your knowledge by walking through the steps of treating your virtual patient. The simulation will provide immediate feedback on your clinical choices and provide an opportunity to reflect and revise your approach to successfully complete the scenario.
How is Your Learning Measured?
The simulation will track your progress throughout the simulation scenarios—see if you can get all 5 stars! When you successfully complete enough scenarios, you will receive your certificate!
This learning platform is designed to meet the educational needs of multidisciplinary specialties that manage the treatment of lung cancer including medical and radiation oncologists, surgeons, pathologists, pulmonologists, interventional radiologists, oncology nurses, and fellows.
Karen Reckamp, MD, MS – Dr. Reckamp is Associate Professor in the Department of Medical Oncology and Therapeutics Research and Co-Director of the Lung Cancer and Thoracic Oncology Program at City of Hope Comprehensive Cancer Center.
Wallace Akerley, MD – Dr. Akerley is Professor of Internal Medicine in the Division of Medical Oncology at the University of Utah School of Medicine and Director of Thoracic Oncology at Huntsman Cancer Institute.
There is no fee to participate in this activity.
This program has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses. Complete accreditation information is provided before the educational activity.
This activity is supported by an independent educational grant from Merck. This activity is supported by educational grants from AstraZeneca, Lilly, and Ethicon.